Evidence map›Paper›PMID 29552107›Full record

ArticleOncology letters2018

Prognostic analysis of patients with locally advanced nasopharyngeal carcinoma following intensity modulated radiation therapy.

Yajie Zhao, Lin Shen, Xinqiong Huang, Yuxiang He, Jun Fu, Yujie Qian, Shan Li, Na Zhao, Liangfang Shen

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yajie ZhaoDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Lin ShenDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Xinqiong HuangDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Yuxiang HeDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Jun FuDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Yujie QianDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Shan LiDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Na ZhaoDepartment of Hospital Management Consulting Center, National Institute of Hospital Administration, Beijing 100083, P.R. China.
Liangfang ShenDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Xiangya Hospital Central South University · CNCentral South University · CNNational Institute of Hospital Administration · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study retrospectively analyzed the prognostic factors of 135 patients with locally advanced nasopharyngeal carcinoma (NPC) who received intensity modulated radiation therapy between August 2008 and January 2012 at Xiangya Hospital of Central South University. Patients were staged from III-IVA according to the 7th American Joint Committee on Cancer staging system. Using Statistical Analysis System 9.3 software, the present study demonstrated that, among these 135 patients, the 5-year overall survival, the 5-year local relapse-free survival, and the 5-year disease metastasis-free survival were 84, 82, and 78%, respectively. Multivariate Cox regression analysis identified that targeted treatment [hazard ratio (95% confidence interval), 2.642 (1.001, 6.972); P=0.0497] served as an independent negative prognostic factor in locally advanced NPC. The results of immunostaining revealed that the staining intensity of the radiation-resistant group was increased compared with that of the radiation-sensitive group. These results demonstrate that a high expression of EGFR may be associated with radiation resistance, and targeted treatment may not be effective in patients with locally advanced nasopharyngeal carcinoma with low expression of EGFR.

Indexed as

immunohistochemistryintensity modulated radiation therapynasopharyngeal carcinomaprognosis factors

Identifiers

PMID29552107
PMCPMC5840609
OpenAlexW2793619171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.